港大零售(01255.HK)與潛在買方終止諒解備忘錄
港大零售(01255.HK)公布,就潛在買方已決定不進行可能交易事項,於昨日(9日)與出售股東訂立終止協議,以終止諒解備忘錄。可能交易事項之要約期於昨日結束。
儘管終止可能交易事項,於昨日出售股東與商贏環球(香港)股份有限公司及主席、該公司執行董事及控股股東楊軍訂立股份轉讓協議,出售股東同意於自轉讓協議日期起計一個半月期間內,以贈與方式向商贏環球轉讓4,280萬股股份,其佔公司已發行股本20%,前提為贈與股份須自出售股東所提供以其貸款人為受益人之現有股份押記中解除。
建議轉讓可能會或可能不會進行。股東及潛在投資者於買賣公司證券時務請審慎行事。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.